Drug Research

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot…
Read More...

Ferring Pharmaceuticals announced the signing of an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a…
Read More...

Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company’s novel cancer vaccine BN-Brachyury for the treatment…
Read More...

OnKure, Inc., the epigenetics-focused drug discovery and development company that is advancing the first Largazole-derived, histone deacetylase inhibitor into Phase 1 clinical trials,…
Read More...

Exelixis announced that it has entered into a collaboration with Invenra, Inc., the Madison, Wisconsin-based biotechnology firm focused on developing next-generation biologics, to…
Read More...

Bactevo Ltd. announced that it has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds. This collaboration…
Read More...

AbbVie announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for risankizumab, an investigational interleukin-23 (IL-23)…
Read More...

Immune Therapeutics announced that the Kenya Pharmacy and Poison Board filed IMUN’s New Drug Application (NDA) for Lodonal, its lead drug candidate, thereby accepting the NDA for a full…
Read More...

Zoetis celebrated the start of construction on a combined global manufacturing and supply and research and development center in Suzhou, China, with a traditional groundbreaking…
Read More...

Innovus Pharmaceuticals announced the launch of its lidocaine-based cream Xyralid, for the relief of pain and symptoms caused by hemorrhoids. Xyralid received a Product License…
Read More...

Family-owned pharmaceutical company Boehringer Ingelheim presented its latest pipeline updates at a Research & Development press conference entitled ‘Transcending Disease…
Read More...

Zymeworks Inc. announced that Celgene Corporation has exercised its right to expand its collaboration agreement for the research, development, and commercialization of bispecific…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra (emicizumab-kxwh) for people with haemophilia A without factor…
Read More...

Sandoz, a Novartis division, announced that it has entered into a collaboration with Pear Therapeutics to commercialize and continued development of novel prescription digital…
Read More...

ProBioGen AG announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held immunology company,…
Read More...

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal. To help…
Read More...

SAMDI Tech, Inc. has partnered with Enamine to expand the number of molecules in their small molecule compound libraries. Through the partnership, SAMDI Tech will be able to offer its…
Read More...

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced that it has signed a collaborative agreement with Plexxikon Inc., the…
Read More...

BioAscent Discovery Limited has announced the launch of a comprehensive suite of integrated drug discovery services with immediate effect. Dr Phil Jones will be joining as Chief…
Read More...

Protagen AG and Gustave Roussy have announced the start of a collaboration to utilize Protagen’s SeroTag technology to help identify biomarkers that predict and monitor immune-related…
Read More...